Concepedia

Katherine E. Burgomaster

KE

Statistics

Publications

13

Citations

761

H-Index

13

Active since

2017

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Moderna Therapeutics (United States)

Takeda (United States)

Washington University in St. Louis

Katherine E. Burgomaster is an author at National Institute of Allergy and Infectious Diseases specializing in infectious diseases, immunology, and vaccinology.

ORCID

Publications per year

2017–2023

13

Publications

13

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito et al. · The Lancet · 2017 · 304 citations · Full text

, , +17

Development of a potent Zika virus vaccine using self-amplifying messenger RNA

Kate Luisi, Kaitlyn M. Morabito, Katherine E. Burgomaster et al. · Science Advances · 2020 · 82 citations · Full text

, , +17

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection

Brooke Bollman, Naveen Nunna, Kapil Bahl et al. · npj Vaccines · 2023 · 58 citations · Full text

, , +17

Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice

Brett W. Jagger, Kimberly A. Dowd, Rita E. Chen et al. · The Journal of Infectious Diseases · 2019 · 53 citations · Full text

, , +17

DNA vaccination before conception protects Zika virus–exposed pregnant macaques against prolonged viremia and improves fetal outcomes

Koen K. A. Van Rompay, Rebekah I. Keesler, Amir Ardeshir et al. · Science Translational Medicine · 2019 · 48 citations · Full text

, , +17

1–5 of 13